Table 3 Relation between patient characteristics and sensory modulation

Gender, male

1.8

-

-

-

-

-

Age

24.8***

24.6***

−0.41***

−0.41***

−0.13

−0.46***

Intelligence (IQ or DQ)

14.2***

5.6***

−0.16

−0.21*

−0.12

0.15

Age at onset of epilepsy

8.7***

ns

-

-

-

-

Seizure frequency

2.0^

ns

-

-

-

-

Etiology

 Genetic

0.6

-

-

-

-

-

 Structural

1.3

-

-

-

-

-

 Metabolic

1.0

-

-

-

-

-

 Unknown

ref

-

-

-

-

-

Distribution, hemisphere

 Left

3.9**

ns

-

-

-

-

 Right

2.1*

ns

-

-

-

-

 Both

ref

ref

-

-

-

-

Distribution, lobe

 Frontal

0.7

-

-

-

-

-

 Temporal

1.5

-

-

-

-

-

 Parietal

0.1

-

-

-

-

-

 Occipital

1.3

-

-

-

-

-

Number of AEDs

4.6**

ns

-

-

-

-

AED-type

 GABA-enhancer

3.3*

ns

-

-

-

-

 Glutamate antagonist

1.9^

ns

-

-

-

-

 Sodium channel blocker

0.5

-

-

-

-

-

 Calcium channel blocker

0.4

-

-

-

-

-

ASD symptoms (SRS)

13.9***

6.3***

0.29**

0.01

0.22*

0.45***

ADHD symptoms (SDQ)

18.3***

7.3***

0.10

0.33***

0.24**

−0.06